UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms

Neuron (Cambridge, Mass.), 2012-02, Vol.73 (4), p.638-652

2012

Volltextzugriff (PDF)

Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology

Nature neuroscience, 2012-08, Vol.15 (8), p.1063-1067

2012

Volltextzugriff (PDF)

TRPA1 is a major oxidant sensor in murine airway sensory neurons

The Journal of clinical investigation, 2008-05, Vol.118 (5), p.1899-1910

2008

Volltextzugriff (PDF)

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Annals of neurology, 2023-03, Vol.93 (3), p.604-614

2023

Volltextzugriff (PDF)

Bacteria activate sensory neurons that modulate pain and inflammation

Nature (London), 2013-09, Vol.501 (7465), p.52-57

2013

Volltextzugriff (PDF)

Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases

The FASEB journal, 2009-04, Vol.23 (4), p.1102-1114

2009

Volltextzugriff (PDF)

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Neurology, 2019-04, Vol.92 (15), p.e1724

2019

Volltextzugriff (PDF)

Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation

Neuron (Cambridge, Mass.), 2015-07, Vol.87 (2), p.341-354

2015

Volltextzugriff (PDF)

Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab

Alzheimer's & dementia, 2024-05, Vol.20 (5), p.3406-3415

2024

Volltextzugriff (PDF)

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1

The New England journal of medicine, 2023-07, Vol.389 (4), p.309-321

2023

Volltextzugriff (PDF)

Loss of Kv3.1 Tonotopicity and Alterations in cAMP Response Element-Binding Protein Signaling in Central Auditory Neurons of Hearing Impaired Mice

The Journal of neuroscience, 2004-02, Vol.24 (8), p.1936-1940

2004

Volltextzugriff (PDF)

TRPA1 Mediates the Noxious Effects of Natural Sesquiterpene Deterrents

The Journal of biological chemistry, 2008-08, Vol.283 (35), p.24136-24144

2008

Volltextzugriff (PDF)

Modulation of the Kv3.1b Potassium Channel Isoform Adjusts the Fidelity of the Firing Pattern of Auditory Neurons

The Journal of neuroscience, 2003-02, Vol.23 (4), p.1133-1141

2003

Volltextzugriff (PDF)

Amino-termini isoforms of the Slack K+ channel, regulated by alternative promoters, differentially modulate rhythmic firing and adaptation

The Journal of physiology, 2008-11, Vol.586 (21), p.5161-5179

2008

Volltextzugriff (PDF)

P1‐041: 24‐MONTH ANALYSIS OF APOE ε4 CARRIERS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_5), p.P283-P283

2018

Volltextzugriff (PDF)

O1‐09‐06: 24‐MONTH ANALYSIS OF CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB

Alzheimer's & dementia, 2018-07, Vol.14 (7S_Part_4), p.P242-P242

2018

Volltextzugriff (PDF)

5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminals

The Journal of neuroscience, 2012-05, Vol.32 (18), p.6364-6372

2012

Volltextzugriff (PDF)

Localization of the Na+-activated K+ channel Slick in the rat central nervous system

Journal of comparative neurology (1911), 2005-03, Vol.484 (1), p.80-92

2005

Volltextzugriff (PDF)

Regulation of the timing of MNTB neurons by short-term and long-term modulation of potassium channels

Hearing research, 2005-08, Vol.206 (1), p.133-145

2005

Volltextzugriff (PDF)

Impact of the Oral Orexin Receptor 2 Agonist TAK-994 on Sustained Attention in Patients with Narcolepsy Type 1: Exploratory Results from a Phase 2 Study (P11-9.012)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia

Neurogenetics, 2007-04, Vol.8 (2), p.131-135

2007

Volltextzugriff (PDF)

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Acta neuropathologica, 2022-07, Vol.144 (1), p.143-153

2022

Volltextzugriff (PDF)

Interim Results of an Open-Label Study to Assess the Effects of Delayed-release Dimethyl Fumarate on Lymphocyte Subsets and Immunoglobulins in Patients with Relapsing-remitting Multiple Sclerosis (P5.380)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Immune response to vaccines is maintained in patients treated with dimethyl fumarate

Neurology : neuroimmunology & neuroinflammation, 2018-01, Vol.5 (1), p.e409-e409

2018

Volltextzugriff (PDF)

Aducanumab titration dosing regimen: 24-month analysis from PRIME, a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.003)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(77)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(35)
Neurosciences & Neurology
(23)
Humans
(19)
Neurosciences
(18)
Animals
(14)
Technology
(13)
Clinical Neurology
(11)
Female
(11)
Mice
(11)
Physical Sciences
(11)
Physics
(11)
Male
(10)
Physics, Applied
(8)
Engineering
(7)
Engineering, Electrical & Electronic
(7)
Materials Science
(7)
Condensed Matter
(6)
Mice, Inbred C57bl
(6)
Psychiatry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms

Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology

TRPA1 is a major oxidant sensor in murine airway sensory neurons

Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome

Bacteria activate sensory neurons that modulate pain and inflammation

Transient receptor potential ankyrin 1 antagonists block the noxious effects of toxic industrial isocyanates and tear gases

Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice

Silencing Nociceptor Neurons Reduces Allergic Airway Inflammation

Results from the long‐term extension of PRIME: A randomized Phase 1b trial of aducanumab

Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1

Loss of Kv3.1 Tonotopicity and Alterations in cAMP Response Element-Binding Protein Signaling in Central Auditory Neurons of Hearing Impaired Mice

TRPA1 Mediates the Noxious Effects of Natural Sesquiterpene Deterrents

Modulation of the Kv3.1b Potassium Channel Isoform Adjusts the Fidelity of the Firing Pattern of Auditory Neurons

Amino-termini isoforms of the Slack K+ channel, regulated by alternative promoters, differentially modulate rhythmic firing and adaptation

P1‐041: 24‐MONTH ANALYSIS OF APOE ε4 CARRIERS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB

O1‐09‐06: 24‐MONTH ANALYSIS OF CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME: A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB

5,6-EET is released upon neuronal activity and induces mechanical pain hypersensitivity via TRPA1 on central afferent terminals

Localization of the Na+-activated K+ channel Slick in the rat central nervous system

Regulation of the timing of MNTB neurons by short-term and long-term modulation of potassium channels

Impact of the Oral Orexin Receptor 2 Agonist TAK-994 on Sustained Attention in Patients with Narcolepsy Type 1: Exploratory Results from a Phase 2 Study (P11-9.012)

Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia

Alzheimer disease neuropathology in a patient previously treated with aducanumab

Interim Results of an Open-Label Study to Assess the Effects of Delayed-release Dimethyl Fumarate on Lymphocyte Subsets and Immunoglobulins in Patients with Relapsing-remitting Multiple Sclerosis (P5.380)

Immune response to vaccines is maintained in patients treated with dimethyl fumarate

Aducanumab titration dosing regimen: 24-month analysis from PRIME, a randomized, double-blind, placebo-controlled Phase 1b study in patients with prodromal or mild Alzheimer’s disease (S2.003)

Suchergebnisse filtern